Literature DB >> 8395556

Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.

W M van Grunsven1, A Nabbe, J M Middeldorp.   

Abstract

The molecular specificity of the IgG response against Epstein-Barr virus (EBV) was studied in 345 randomly collected sera of normal healthy individuals. The sera were tested on immunoblots containing antigens of the cell line HH514.c16 (a superinducible derivate of P3HR1), noninduced or induced for the expression of early antigens (EA) or viral capsid antigens (VCA), and from the EBV-negative cell line Ramos-Nut. This study reveals a remarkable similar antigen recognition pattern of IgG class antibodies in sera of healthy EBV carriers. The protein bands recognized predominantly have molecular weights of 18 kD, 36/38 kD, 40 kD, 72 kD, and 160 kD. The 72 kD and 36/38 kD bands were identified as EBNA1 and "Zebra," respectively, using reading frame-specific antisera. The bands at 160 kD (major capsid protein), 40 kD, and 18 kD were identified as VCA-class proteins. Of all EBV-seropositive sera tested, 98% reacted with either p18 or p40 or both. The synthesis of the antigens p18 and p40 was inhibited by phosphonoacetic acid, indicating that these were true late proteins. The detection of p18 and p40 in purified virion and capsid preparations confirms that these proteins are structural components of viral capsid antigen complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395556     DOI: 10.1002/jmv.1890400215

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

1.  Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.

Authors:  D Tranchand-Bunel; H Gras-Masse; B Bourez; L Dedecker; C Auriault
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Evidence of an oncogenic gammaherpesvirus in domestic dogs.

Authors:  Shih-Hung Huang; Philip J Kozak; Jessica Kim; Georges Habineza-Ndikuyeze; Charles Meade; Anita Gaurnier-Hausser; Reema Patel; Erle Robertson; Nicola J Mason
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

3.  Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Authors:  Nina Orlova; Mark H Fogg; Angela Carville; Fred Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

4.  Application of a commercial immunoblot to define EBV IgG seroprofiles.

Authors:  Fernando de Ory; Eulalia Guisasola; David Tarragó; Juan Carlos Sanz
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

5.  Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.

Authors:  Kelly J Yu; Wan-Lun Hsu; Ruth M Pfeiffer; Chun-Ju Chiang; Cheng-Ping Wang; Pei-Jen Lou; Yu-Juen Cheng; Patti Gravitt; Scott R Diehl; Alisa M Goldstein; Chien-Jen Chen; Allan Hildesheim
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

6.  Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate.

Authors:  Mark H Fogg; Angela Carville; Jennifer Cameron; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350.

Authors:  Julien Batisse; Evelyne Manet; Jaap Middeldorp; Alain Sergeant; Henri Gruffat
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.

Authors:  E K Hoebe; S H Hutajulu; J van Beek; S J Stevens; D K Paramita; A E Greijer; J M Middeldorp
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

9.  Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).

Authors:  T R Serio; A Angeloni; J L Kolman; L Gradoville; R Sun; D A Katz; W Van Grunsven; J Middeldorp; G Miller
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

10.  Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.

Authors:  Dewi K Paramita; Jajah Fachiroh; Sofia M Haryana; Jaap M Middeldorp
Journal:  Clin Vaccine Immunol       Date:  2009-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.